First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely

During the last 15 years, tremendous efforts have been made toward medical treatment of metastatic renal cell carcinoma (mRCC). Checkpoint inhibitors (CPI) and tyrosine kinase inhibitors (TKI) dominate the therapeutic armamentarium, as a combination of either CPIs or CPI/TKI, while the value of TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanyi, Philipp, Wiegmann, Jonas Paul, Eggers, Hendrik, Grünwald, Viktor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427551/
https://www.ncbi.nlm.nih.gov/pubmed/37438555
http://dx.doi.org/10.1007/s12325-023-02571-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427551/
https://www.ncbi.nlm.nih.gov/pubmed/37438555
http://dx.doi.org/10.1007/s12325-023-02571-5

Ejemplares similares